Trending...
- California: Governor Newsom announces appointments 9.10.25 - 274
- John Thomas calls for unity and prayer after tragic loss - 247
- Ayurveda, Ayurvedic medical Science and Ayurvedic Therapies, Dr.Abhay Kumar Pati - 238
SAN DIEGO, Sept. 29, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, has announced the planned agenda for the Company's Investor Day 2022, which will be hosted at the NuVasive West Coast Experience Center in San Diego on Thursday, October 6, 2022, with presentations beginning at 9:00 a.m. PT.
Investor Day 2022 will be a hybrid event, with in-person attendance available to members of the investment community, and a simultaneous, virtual webcast for individual investors, media, and other interested parties. Those attending in person will have the opportunity to see demonstrations of the Company's comprehensive, procedurally integrated solutions including the C360 and X360 portfolios—as well as the Pulse platform—in the NuVasive West Coast Experience Center's cadaveric lab and procedural showcase area.
Chris Barry, chief executive officer, will speak to updates about the Company's strategy and its plans to continue delivering value to stakeholders through leadership and market share expansion opportunities. Ryan Donahoe, chief technology officer, will showcase the Company's full-line spine portfolios and robust innovation pipeline. Matt Harbaugh, chief financial officer, will provide long-range financial goals through 2027, including the Company's near- and longer-term capital allocation plan.
More on The Californer
Advance registration is required. The agenda and registration link can be found on the Company's Investor Relations section of its website at www.nuvasive.com. A replay of the event will be available online after the event. Presentation materials will also be available for download on the Company's website and will be archived.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release and the associated event and webcast that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions, and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding the Company's preliminary expectations for 2022 and longer‐term financial and business goals; our plans for future product development and enhancements of existing products; and our beliefs and expectations regarding our market penetration and expansion efforts. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the risk that NuVasive's financial guidance and expectations may turn out to be inaccurate because of the preliminary nature of the Company's forecasts and projections; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating revenue or producing expected growth and profitability; the risk that acquisitions will not be integrated successfully or that the benefits and synergies from the acquisition may not be fully realized or may take longer to realize than expected; the loss of key employees; unexpected variations in market growth and demand for the Company's products and technologies; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
More on The Californer
SOURCE NuVasive, Inc.
Investor Day 2022 will be a hybrid event, with in-person attendance available to members of the investment community, and a simultaneous, virtual webcast for individual investors, media, and other interested parties. Those attending in person will have the opportunity to see demonstrations of the Company's comprehensive, procedurally integrated solutions including the C360 and X360 portfolios—as well as the Pulse platform—in the NuVasive West Coast Experience Center's cadaveric lab and procedural showcase area.
Chris Barry, chief executive officer, will speak to updates about the Company's strategy and its plans to continue delivering value to stakeholders through leadership and market share expansion opportunities. Ryan Donahoe, chief technology officer, will showcase the Company's full-line spine portfolios and robust innovation pipeline. Matt Harbaugh, chief financial officer, will provide long-range financial goals through 2027, including the Company's near- and longer-term capital allocation plan.
More on The Californer
- WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
- Vesica Health Receives AUA Guideline Inclusion
- Steward's Plumbing Sponsors the 2025 Samson Challenge, Bringing Community, Fitness, and Fun Together in Albuquerque
- Machine Vision Products Unveils New Homepage at Visionpro.com
- Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences
Advance registration is required. The agenda and registration link can be found on the Company's Investor Relations section of its website at www.nuvasive.com. A replay of the event will be available online after the event. Presentation materials will also be available for download on the Company's website and will be archived.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release and the associated event and webcast that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions, and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding the Company's preliminary expectations for 2022 and longer‐term financial and business goals; our plans for future product development and enhancements of existing products; and our beliefs and expectations regarding our market penetration and expansion efforts. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the risk that NuVasive's financial guidance and expectations may turn out to be inaccurate because of the preliminary nature of the Company's forecasts and projections; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating revenue or producing expected growth and profitability; the risk that acquisitions will not be integrated successfully or that the benefits and synergies from the acquisition may not be fully realized or may take longer to realize than expected; the loss of key employees; unexpected variations in market growth and demand for the Company's products and technologies; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
More on The Californer
- California: Governor Newsom proclaims Latino Heritage Month
- MEDIA ALERT: Cisco's WebexOne Event Spotlights Global AI Brands and Ryan Reynolds, Acclaimed Actor, Film Producer, and Entrepreneur
- Patrick Perez Steps Beyond Crunchyroll to Shape the Next Wave of Streaming & Media Innovation
- Mesa West Capital Originates $43.5 Million Loan to Refi LA Area Apartment Community
- 10xLaw.com Extends Employment Opportunity to Kim Kardashian
SOURCE NuVasive, Inc.
Filed Under: Business
0 Comments
Latest on The Californer
- Twice the Laughs: Comedy Star Don Barnhart Rotates Residency at Both Delirious Comedy Club Locations in Las Vegas
- Voices for Humanity Ignites a Revolution for Learning with Eva Rehorova
- Omnigarde AI-Powered Face Recognition Achieves Top Global Rankings in Prestigious NIST Evaluation
- Petitioner Urges White House to Issue Executive Order on Divorce Fairness
- Car Wash Deal in Downey CA Prices Starting from $8
- Dr. Vincent Malfitano Elected to Central Council of The Italian Catholic Federation, National Gov
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Long Beach Recognizes September as National Preparedness Month, Relaunches Program to Connect Neighborhoods to Disaster Planning Resources
- SEEAG Adds Santa Barbara County Office, Student & Community Agriculture Learning Programs
- California claims victory – again – over Huntington Beach as appeals court rules against city's NIMBY violations of state law
- The Great Junk Hunt Returns to Roseville – A Vintage Shopping Adventure Awaits!
- Erdos Technologies CEO Dan Herbatschek Emphasizes the Importance of Software in Helping Companies Make More Intelligent Decisions on Inventory Flow and Management
- MyNamePlayer Empowers Educators to Create Inclusive Classrooms Through Correct Name Pronunciation
- Long Beach Seeks Volunteers for 41st Annual California Coastal Cleanup Day, September 20
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Wise Business Plans Launches Business Plan Writing Services in San Diego to Propel Entrepreneurs
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- Apex Raises $200 Million Series D Financing
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience